Drugs News and Research

RSS

LGC licenses first DNA test for response to schizophrenia treatment from the Institute of Psychiatry, King’s College London

LGC, Europe's leading independent analytical laboratory providing advanced chemical, biochemical and forensic analysis, has announced an exclusive agreement with King’s College London to offer the first pharmacogenetic screening service which will predict whether a patient with schizophrenia will respond positively to the antipsychotic drug clozapine.

8 Nov 2005

Sildenafil reverses symptoms of Raynaud's

German researchers have discovered yet another use for Viagra (sildenafil), they say it relieves the symptoms and improves the circulation of patients with Raynaud's phenomenon.

8 Nov 2005

Aspirin may prevent skin cancer

Australian scientists say that common drugs such as aspirin may hold the key to reducing the risk of developing skin cancer.

8 Nov 2005

Those most at risk of Alzheimer's would allow loved ones enroll them in research

According to a new survey most people at high risk of Alzheimer's disease would be willing to have their loved ones enroll them in research studies when they could no longer give consent themselves.

8 Nov 2005

Statin drug reverses learning and attention deficits in a mouse model of the genetic disorder Neurofibromatosis type I

This week, researchers report evidence that a statin drug already shown to be safe for use in humans has proven effective at correcting cell-cell communication and curing learning disfunction in a mouse model of Neurofibromatosis type I, a human genetic disorder that causes learning disabilities in millions of people worldwide.

7 Nov 2005

Should Alzheimer's sufferers take part in research?

Grandma has Alzheimer's disease - should you sign her up for a new research study, even if she doesn't really understand what it entails?

7 Nov 2005

Cholesterol lowering drugs do not appear to decrease the risk of melanoma

No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.

7 Nov 2005

New VariDose device will reduce pharmaceutical R&D costs

A new optical instrument that could vastly reduce the amount of time the pharmaceutical industry spends in R&D, by speeding up the measurement of drug inhaler performance, is being launched by Loughborough University spin out VariDose Limited.

7 Nov 2005

Diagnostics test for monitoring anti-HIV drugs hits European market

The test has been acquired by Delphic Europe - a diagnostics products provider - which will develop it in conjunction with viral resistance testing for market on the continent. The service was created by Professor David Back, Dr Saye Khoo and a team in the School of Biomedical Science and is currently used to analyse blood samples from patients with HIV across the UK in order to identify the correct dosage of medicine for individual patients.

7 Nov 2005

Studies outline dangers of mixing stress, deprivation and tempting foods

Two studies in the October issue of Behavioral Neuroscience show that when animals are stressed, deprived and exposed to tempting food, they overeat, with different degrees of interaction.

7 Nov 2005

Anti-aging hormone called Klotho actions explained

Scientists recently discovered an anti-aging hormone called Klotho. Now, a new study shows that this protein acts by increasing the cell's ability to detoxify harmful reactive oxygen species.

7 Nov 2005

Important that GP's take flu pandemic threat seriously

Family doctors are advised to plan their response to managing a flu pandemic in this week's BMJ.

7 Nov 2005

Herceptin results beg questions on equal access to expensive drugs

The recent press coverage on the use of Herceptin (brand name for the drug trastuzumab) for treating breast cancer in its early stages shows that issues of equal access to costly but effective drugs must be confronted, says an editorial in the British Medical Journal.

7 Nov 2005

America will not have a high-quality health system if equal attention is not given to mental health issues and substance-use problems

Without a comprehensive strategy to improve the quality of health care for people with mental conditions and alcohol or drug problems, high-quality care in the nation's overall health system and better health for the public are goals that will remain unmet

7 Nov 2005